NEW YORK (GenomeWeb News) – Prodesse’s molecular diagnostic test for H1N1 swine flu infections has been cleared by EU regulators for commercialization in Europe.

The firm, which recently became a subsidiary of Gen-Probe, received the CE Mark clearance for its ProFlu-ST assay as a diagnostic to differentiate among influenza strains.

The RT-PCR-based test detects and identifies the 2009 H1N1 virus, the seasonal influenza A/H1 virus, and the seasonal A/H3 virus.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.